Sun et al. demonstrated that high expression of the TAMs CD68 or M2 CD206 usually predicted low overall survival, while high expression of M1 macrophages (CD86) is associated with a favorable prognosis in HER2-positive patients with GC [111]. The gene discussed is ERBB2; the disease is gastric cancer.